Vitamin D regulation of energy metabolism in cancer.
Madeline P SheeleyChaylen AndolinoViolet A KieselDorothy TeegardenPublished in: British journal of pharmacology (2021)
Vitamin D exerts anti-cancer effects in recent clinical trials and preclinical models. The actions of vitamin D are primarily mediated through its hormonal form, 1,25-dihydroxyvitamin D (1,25(OH)2 D). Previous literature describing in vitro studies has predominantly focused on the anti-tumourigenic effects of the hormone, such as proliferation and apoptosis. However, recent evidence has identified 1,25(OH)2 D as a regulator of energy metabolism in cancer cells, where requirements for specific energy sources at different stages of progression are dramatically altered. The literature suggests that 1,25(OH)2 D regulates energy metabolism, including glucose, glutamine and lipid metabolism during cancer progression, as well as oxidative stress protection, as it is closely associated with energy metabolism. Mechanisms involved in energy metabolism regulation are an emerging area in which vitamin D may inhibit multiple stages of cancer progression.
Keyphrases
- papillary thyroid
- oxidative stress
- clinical trial
- squamous cell
- systematic review
- stem cells
- randomized controlled trial
- dna damage
- squamous cell carcinoma
- endoplasmic reticulum stress
- young adults
- cell death
- bone marrow
- drinking water
- insulin resistance
- heat stress
- mesenchymal stem cells
- blood glucose
- diabetic rats
- phase ii
- study protocol
- heat shock protein
- double blind